We sit down with you and build your perfect lead list. Book a call with founders.
Sign Up
Login

Cisterna Biologics Analysis: $500K Raised

What is Cisterna Biologics?

Cisterna Biologics develops high-quality mRNA for therapeutic applications, focusing on innovative production technologies to advance mRNA-based treatments.

Founded
2022
Company Stage
Pre-Seed
Investors
- Y Combinator - National Science Foundation
YC Batch
S22

Product Features & Capabilities

  • dT-purified mRNA, SPECC-purified mRNA, high-quality mRNA for therapeutic applications, advanced mRNA production technology, solutions for mRNA-related impurities

How much Cisterna Biologics raised

1: - $500,000

August 22, 2022
Lead Investor: Y Combinator, National Science Foundation

Find more companies like Cisterna Biologics

in Y Combinator Batch S22 Companies

Financial Overview

$500KTotal Raised
1:$500,000
August 22, 2022
Investors: Y Combinator, National Science Foundation
Want to research more data points on Cisterna Biologics?
Start with Extruct

Platform Links

LinkedInFollow on LinkedInWebsiteOfficial WebsitePitchBookView on PitchBookZoomInfoView on ZoomInfoDPADPA
Extruct
© Copyright 2025, All Rights Reserved
Linkedin